Merck is your provider for confidently advancing your drug pipeline from discovery to market. We extend your capabilities by combining our scientific knowledge, regulatory expertise and flexibility, with the trusted, relevant information required for your drug discovery and development needs. 
GPCRs: HTS-quality ChemiScreen™ membrane preps, Ready-to-Assay™ frozen cells for drug screening and profiling
Ion Channels: hERG membrane preparations for cardiotoxicity assessment 
Kinases & Phosphatases: Upstate® enzymes and HTRF® assay kits for drug discovery 
Ubiquitin:  Remove the complexity of ubiquitin signaling with active enzymes and assays for 20+ ubiquitin pathways 
ADME & in vitro Toxicology:  HepaRG™ terminally differentiated cells that express native transporters and drug metabolizing enzymes  
Strat-M® Transdermal Diffusion Membrane: Experience the unmatched predictability of Strat-M® membrane — a synthetic, non-animal based model for transdermal diffusion testing that is predictive of diffusion in human skin without lot-to-lot variability, safety and storage limitations. 
Discovery & Bioanalytical Services
These services are now part of Eurofins. 
|  | Visit the Eurofins site for Bioanalytical Services
 
 
Biomarker AnalysisImmunogenicity Testing Pharmacokinetics TestingcGMP ServicesBiosimilar Testing | 
 
Featured Resources
|  Featured Webinar Clinical Flow Cytometry Outsourcing
 
 Topic: Flow Cytometry Analysis of Clinical Trial Samples
 
 Speaker: Kevin Maskell,
 Principal Scientific Director, Discovery & Development Solutions, Merck
 |  Featured Applications Detecting Substrate Ubiquitination Using Quantitative Assays
 |